This company has been marked as potentially delisted and may not be actively trading. NASDAQ:BSGM Biosig Technologies (BSGM) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Biosig Technologies Stock (NASDAQ:BSGM) Get Biosig Technologies alerts:Sign Up Key Stats Today's Range$4.36▼$6.1250-Day Range$3.68▼$6.3552-Week Range$0.59▼$14.11Volume3.10 million shsAverage Volume1.08 million shsMarket Capitalization$199.35 millionP/E RatioN/ADividend YieldN/APrice Target$10.00Consensus RatingBuy Company Overview Biosig Technologies, Inc. is a clinical-stage medical device company developing advanced signal acquisition and processing systems for interventional electrophysiology. Its lead product, the PURE EP™ System, is designed to enhance the quality and reliability of intracardiac recordings during diagnostic and therapeutic procedures for cardiac arrhythmias, including atrial fibrillation and other rhythm disorders. The PURE EP™ System integrates proprietary hardware and software to deliver higher-fidelity electrograms, helping physicians distinguish true cardiac signals from noise. Biosig Technologies is collaborating with electrophysiology labs and research institutions across the United States to conduct clinical studies and support regulatory filings aimed at expanding market access for its platform. Founded in the early 2010s and headquartered in New York, Biosig Technologies has pursued U.S. Food and Drug Administration (FDA) regulatory clearance for its flagship device and initiated preparations for European CE mark registration. The company’s pipeline also includes software upgrades and ancillary tools intended to further improve procedural workflows and patient outcomes. Under the leadership of President and Chief Executive Officer Kenneth L. Londoner, Biosig Technologies is positioning its PURE EP™ platform to address unmet needs in the growing field of cardiac rhythm management. By offering enhanced signal clarity and analytic capabilities, the company aims to become a preferred partner for electrophysiologists seeking innovative technologies to optimize interventional procedures.AI Generated. May Contain Errors. Read More Biosig Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreBSGM MarketRank™: Biosig Technologies scored higher than 34% of companies evaluated by MarketBeat, and ranked 747th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingBiosig Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.Upside PotentialBiosig Technologies has a consensus price target of $10.00, representing about 57.6% upside from its current price of $6.35.Amount of Analyst CoverageBiosig Technologies has received no research coverage in the past 90 days.Read more about Biosig Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Biosig Technologies are expected to grow in the coming year, from ($0.88) to ($0.73) per share. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for BSGM. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBiosig Technologies does not currently pay a dividend.Dividend GrowthBiosig Technologies does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A Search Interest1 people have searched for BSGM on MarketBeat in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Biosig Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders24.80% of the stock of Biosig Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions7.16% of the stock of Biosig Technologies is held by institutions.Read more about Biosig Technologies' insider trading history. Receive BSGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biosig Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BSGM Stock News HeadlinesStreamex Corp., NASDAQ: STEX & Simplify Asset Management $10 billion USD AUM ETF Manager Announces Letter of Intent Pursuing a Strategic Partnership to Drive ETF Innovation through Integration of Tokenized Gold Yield Assets and Tokenization of Existing ETFsSeptember 17, 2025 | globenewswire.comStreamex Corp., NASDAQ: STEX & Simplify Asset Management $10 billion USD AUM ETF Manager Announces Letter of Intent Pursuing a Strategic Partnership to Drive ETF Innovation through Integration of Tokenized Gold Yield Assets and Tokenization of Existing ETFsSeptember 17, 2025 | globenewswire.comStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar.June 2 at 1:00 AM | Porter & Company (Ad)BioSig Technologies changing name to Streamex, ticker to ‘STEX’September 10, 2025 | msn.comBioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.September 10, 2025 | globenewswire.comMonetary Metals Enters into Exclusive Partnership with Streamex (Nasdaq: BSGM) to Create Tokenized Yield-Bearing Gold ProductsSeptember 9, 2025 | prnewswire.comBiosig Technologies trading halted, news pendingSeptember 8, 2025 | msn.comBioSig Technologies Partners with Monetary Metals for BlockchainSeptember 8, 2025 | msn.comSee More Headlines BSGM Stock Analysis - Frequently Asked Questions How were Biosig Technologies' earnings last quarter? Biosig Technologies, Inc. (NASDAQ:BSGM) posted its quarterly earnings data on Friday, August, 15th. The company reported ($0.74) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.70. When did Biosig Technologies' stock split? Biosig Technologies shares reverse split on the morning of Friday, February 2nd 2024.The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Biosig Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biosig Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Citius Pharmaceuticals (CTXR), Roku (ROKU) and Ford Motor (F). Company Calendar Last Earnings8/15/2025Today6/02/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:BSGM CIK1530766 Webwww.biosig.com Phone(230) 409-5444FaxN/AEmployees50Year Founded2009Price Target and Rating Average Price Target for Biosig Technologies$10.00 High Price Target$10.00 Low Price Target$10.00 Potential Upside/Downside+57.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.33 million Net MarginsN/A Pretax Margin-201,392.33% Return on Equity-5,336.99% Return on Assets-90.03% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.03 Sales & Book Value Annual Sales$13 thousand Price / Sales15,334.89 Cash FlowN/A Price / Cash FlowN/A Book Value($0.09) per share Price / Book-70.50Miscellaneous Outstanding Shares31,419,000Free Float23,627,000Market Cap$199.35 million OptionableNo Data Beta1.82 Social Links 7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:BSGM) was last updated on 6/2/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredA gold storm is coming – are you ready?The U.S. Treasury Secretary is betting big on gold - and the world's most successful investors are following s...Traders Agency | SponsoredPresident Trump just sparked a stock market MELT UPThe real reason Musk, Huang, Cook, and Fink just flew to Beijing Last week, the CEOs of Nvidia, Apple, Spac...Stansberry Research | SponsoredGold hit $4,500 - but these miners haven't caught up yet$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...Golden Portfolio | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biosig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biosig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
